Abcam founder’s activist campaign draws attention to shareholder rights at European pharma companies with a US listing
UK-based protein research tools company Abcam has attracted interest from “pure-play” lab tools providers, as well as pharma companies with a broader offering, a person briefed on the process told Equity Report. Last month, the …